<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200913048706N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-14</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of dry needling technique on spasticity and function in stroke patients</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the short term effects of wrist flexor dry needling versus LI4 &amp; TE5 acupuncture points dry needling on upper limb spasticity and function, in stroke patients: A Double-Blinded Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52090</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: According to the number of patients in each group, the particular sort of treatment, either "wrist flexor dry needling" or "LI4&amp;TE5 acupuncture points dry needling," is written on a piece of paper, and the paper is placed in Opaque sealed envelopes. The envelopes are then mixed. At the first visit session of each individual, the therapist who will not be involved in outcomes assessment will randomly select one of the envelopes. Based on the written sort of treatment specified, the therapist will do the patient's particular treatment. If any of the patients, for any reason, is omitted from the study, one envelope with the particular topic will be added again by the examiner, and they will be mixed again, Blinding description: Although at first, the necessary explanation about the aims of the project and the existence of two groups are given to the patients, no explanation is given to them about the difference between the treatment methods. Besides, the patient's treatment sessions will be arranged so that the two groups' patients have no contact with each other and are not aware of the other group's treatment method. In this way, patients are blind regarding the treatment method. In addition, the allocation of participants into each of the treatment groups will be done by the therapist who performed the DN, and their clinical evaluation will be performed by another examiner who is not aware of the treatment group. So the examiner also is blind to the specific treatment method of each participant.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:wrist flexor dry needling including flexor carpi ulnaris and flexor carpi radialis in supine position and forearm in supination with filiform needles. The technique is done in the Fast in - Fast out method for one minute for each muscle / point. The number of treatment sessions is three sessions during a week. Intervention 2: Intervention group 2: LI4 &amp; TE5 acupuncture points dry needling in supine position and forearm in pronation with filiform needles. The technique is done in the Fast in - Fast out method for one minute for each muscle / point. The number of treatment sessions is three sessions during a week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The raw data of research and its analysis will be available to researchers if they request it.

When:
After the publication of articles resulting from the research.

To whom:
Researchers working in academic institutions.

Conditions:
The data are available only to other researchers to study and evaluate treatment outcomes.

Where to obtain:
By sending an email to the corresponding author.

How to obtain:
Sending an Email to the corresponding author and request the data.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Najmeh Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physiotherapy Department, School of Rehabilitation, Pich-e-Shemiran., Enghelab St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11489-65111</zip>
        <telephone>+98 21 7753 5132</telephone>
        <email>Najmeh_Nazari@outlook.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Najmeh Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physiotherapy Department, School of Rehabilitation, Pich-e-Shemiran., Enghelab St</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11489-65111</zip>
        <telephone>+98 21 7753 5132</telephone>
        <email>Najmeh_Nazari@outlook.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age ≥18 years old
First-ever stroke resulted in hemiplegia
Disease duration of at least six months
Wrist flexor Modified Modified Ashworth Scale (MMAS) spasticity score ≥1
Active and passive range of motion of the involved wrist is at most 10% less than the non-involved side</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Have neurological disorders or diabetes
Inability to follow the therapist's instructions
Have contraindications to Dry Needling
Have participation simultaneously in another clinical trial
Have injections with botulinum toxin in the 6 months preceding the study
Taking antispastic drug</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Brain stem stroke syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:wrist flexor dry needling including flexor carpi ulnaris and flexor carpi radialis in supine position and forearm in supination with filiform needles. The technique is done in the Fast in - Fast out method for one minute for each muscle / point. The number of treatment sessions is three sessions during a week.</i_keyword>
      <i_keyword>Intervention group 2: LI4 &amp; TE5 acupuncture points dry needling in supine position and forearm in pronation with filiform needles. The technique is done in the Fast in - Fast out method for one minute for each muscle / point. The number of treatment sessions is three sessions during a week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Spasticity. Timepoint: Before intervention, immediately after intervention, and one week after intervention. Method of measurement: Modified Modified Ashworth Scale.</prim_outcome>
      <prim_outcome>Function. Timepoint: Before intervention, immediately after intervention, and one week after intervention. Method of measurement: Fugl-Meyer assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Active Range Of Motion(ROM). Timepoint: Before intervention, immediately after intervention, and one week after intervention. Method of measurement: Goniometer.</sec_outcome>
      <sec_outcome>Passive Range Of Motion(ROM). Timepoint: Before intervention, immediately after intervention, and one week after intervention. Method of measurement: Goniometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-18</approval_date>
        <contact_name>Ethics committee of Nursing and Midwifery &amp; Rehabilitation Schools- Tehran University of Medical Sci</contact_name>
        <contact_address>Quds Ave., Keshavarz Blvd, Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
